Drug news
Novasight Hybrid imaging system receives 510(k) FDA approval.- Conavi.
Conavi has received 510(k) clearance from the FDA for its Novasight Hybrid System. The system enables simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and Optical Coherence Tomography (OCT). IVUS or OCT are typically used by interventional cardiologists to image coronary anatomy during angioplasty and stenting procedures.